KHC
AMGN icon

Koesten Hirschmann & Crabtree’s Amgen AMGN Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-251
Closed -$70.9K – 49
2025
Q3 		$70.9K Hold
251
– – 0.03% 68
2025
Q2 		$70.2K Hold
251
– – 0.04% 68
2025
Q1 		$78.3K Hold
251
– – 0.04% 67
2024
Q4 		$65.5K Hold
251
– – 0.04% 69
2024
Q3 		$81K Hold
251
– – 0.05% 62
2024
Q2 		$71.5K Hold
251
– – 0.05% 69
2024
Q1 		$71.5K Hold
251
– – 0.05% 69
2023
Q4 		$72.4K Hold
251
– – 0.05% 59
2023
Q3 		$67.5K Hold
251
– – 0.05% 49
2023
Q2 		$55.8K Hold
251
– – 0.04% 53
2023
Q1 		$60.8K Hold
251
– – 0.05% 54
2022
Q4 		$66K Buy
+251
New +$67.3K 0.05% 53

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Koesten Hirschmann & Crabtree's AMGN Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Amgen (AMGN) in Q4 2025, closing a stake of 251 shares — an estimated $70.9K sold.

Koesten Hirschmann & Crabtree first reported a position in AMGN in Q4 2022 and held it in 12 quarters. The position peaked at $81K in Q3 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 251 Amgen shares in Q4 2025, an estimated $70.9K.
  • Koesten Hirschmann & Crabtree first reported a position in Amgen in Q4 2022 and held it in 12 quarters.
  • Koesten Hirschmann & Crabtree's Amgen position peaked at $81K in Q3 2024.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.